Published in Cancer Weekly, July 20th, 2004
"The liver is second only to lymph nodes as the most common site of metastatic disease irrespective of the primary tumor," radiologists in Germany noted. "Up to 50% of all patients with malignant diseases will develop liver metastases with a significant morbidity and mortality. Although surgical resection leads to an improvement of the survival time, only approximately 20% of the patients are eligible for surgical intervention."
RF ablation "represents one of the most important alternatives as well as complementary methods for the therapy of liver metastases,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.